BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23676783)

  • 1. Toxic corneal epitheliopathy after intravitreal methotrexate and its treatment with oral folic acid.
    Gorovoy I; Prechanond T; Abia M; Afshar AR; Stewart JM
    Cornea; 2013 Aug; 32(8):1171-3. PubMed ID: 23676783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
    Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal epithelial toxicity with intravitreal methotrexate in a case of B-cell lymphoma with ocular involvement.
    Sahay P; Maharana PK; Temkar S; Chawla R
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients.
    Zhou X; Zhou X; Shi H; Lai J; Wang Q; Li Y; Chen K; Li Q; Zhou Q; Cao X; Chen B; Xiao J
    BMC Ophthalmol; 2020 May; 20(1):189. PubMed ID: 32397978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyewash with balanced salt solution after intravitreal methotrexate injection in a case of vitreoretinal lymphoma: a simple but effective way to prevent ocular surface toxicity.
    Moharana B; Parija S; Palanisamy S; Mishra P
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37474142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual presentation of cornea verticillata with intravitreal methotrexate in a case of primary intraocular lymphoma.
    Hasan N; Narde HK; Das AK; Chawla R
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35027386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal Epithelial Toxicity after Intravitreal Methotrexate Injection for Vitreoretinal Lymphoma: Clinical and In Vitro Studies.
    Jeong Y; Ryu JS; Park UC; Oh JY
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32824794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z; Frenkel S; Pe'er J
    Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
    Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial experience of treatment of primary intraocular lymphomas associated with primary CNS lymphomas].
    Tropinskaia OF; Grishina EE; Serova NK; Kobiakov GL; Aronov MS; Shishkina LV
    Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):19-25; discussion 25. PubMed ID: 23033588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
    Kim E; Kim C; Lee J; Cho Y
    Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study.
    Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.